NurExone Biologic Inc.

Public

NurExone Biologic Inc. is now publicly traded

The data on this page reflects NurExone Biologic Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Jul 2, 2026

Total Funding Raised

$721,689

Company Overview

NurExone Biologic Inc. is a pharmaceutical technology company developing a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries.

Sector

Healthcare

AI Layer

Non-AI

Keywords

exosome therapyspinal cord injury treatmentnerve regenerationExoPTENsiRNA therapydrug delivery platformregenerative medicineSCI treatmentPTEN inhibitionCNS injury treatmentintranasal drug deliveryexosome manufacturingRNAi therapygene silencingextracellular vesiclestraumatic brain injury treatmentoptic nerve injurybiologics development

NurExone Biologic Inc. Comparables

Compare NurExone Biologic Inc. with similar companies based on industry and business-model similarity.

NurExone Biologic Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Aruna Bio, Inc.	79%
VivaZome Therapeutics	78%
ReNetX Bio	76%

View all Comparables

NurExone Biologic Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Jul 2, 2026
Private Placement	Mar 18, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Lior Shaltiel

Chief Executive Officer

Executive Team

Eran Ovadya

Chief Financial Officer

Executive Team

NurExone Biologic Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

NurExone Biologic Inc. Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersCanada

Employee Range28

Year Founded2020

Last FundingJul 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.